Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Modular Medical Announces it's Insulin Pump Is Close to Commercial Launch
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
Dexcom Releases New “Trends” Tab on the Dexcom G7 App
Dexcom's G7 Trends tab offers users more diabetes insights, showcasing time in range, sensor usage, and key metrics, with more insights expected in the future.
The FDA Warns Abbott Over Libre CGM Accuracy Concerns
Following a 2025 recall of millions of sensors, the FDA points to gaps in Abbott’s quality verification process, sparking renewed discussion on device reliability.
Diabetech's most viral social media shorts of 2025 highlighting CGM failures, insulin pump breakthroughs, wearables, and unfiltered real-life experiences.
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
FreeStyle Libre App Gets Apple Watch App & AI Food Assistant
The updated Libre app brings Apple Watch support and a new feature called Libre Assist which uses AI meal analysis giving Libre users insights for meals.
